Utility-based Quality of Life Measures in Alzheimer’s Disease

Overview of attention for article published in Quality of Life Research, May 2006

Altmetric Badge

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 105 Dimensions

Readers on

mendeley: 112 Mendeley

Summary Policy documents Dimensions citations

So far, Dimensions has found 105 publications that cite this research output.

105

The most recent citing publications are shown below. View all 105 publications that cite this research output on Dimensions.

Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment

Article in Applied Health Economics and Health Policy (March 2024)

Transcriptome profiling of cerebrospinal fluid in Alzheimer’s Disease reveals molecular dysregulations associated with disease

Preprint in medRxiv (November 2023)

A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial

Article in Health Technology Assessment (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.